DA
LLY icon

Dover Advisors’s Eli Lilly LLY Stock Holding History

Dover Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Sell
1,605
-20
-1% -$20.3K 0.61% 45
2025
Q4 		$1.75M Buy
1,625
+93
+6% +$88.9K 0.68% 43
2025
Q3 		$1.17M Sell
1,532
-1
-0.1% -$744 0.47% 54
2025
Q2 		$1.2M Buy
1,533
+32
+2% +$24.9K 0.53% 51
2025
Q1 		$1.24M Sell
1,501
-33
-2% -$27.5K 0.54% 52
2024
Q4 		$1.18M Hold
1,534
– – 0.68% 50
2024
Q3 		$1.36M Sell
1,534
-13
-0.8% -$11.7K 0.77% 42
2024
Q2 		$1.4M Sell
1,547
-18
-1% -$14.4K 0.87% 36
2024
Q1 		$1.22M Buy
1,565
+120
+8% +$85.4K 0.83% 38
2023
Q4 		$842K Sell
1,445
-388
-21% -$226K 1.11% 31
2023
Q3 		$985K Sell
1,833
-8
-0.4% -$4.12K 1% 35
2023
Q2 		$863K Sell
1,841
-336
-15% -$141K 0.77% 44
2023
Q1 		$748K Buy
2,177
+340
+19% +$115K 0.72% 48
2022
Q4 		$672K Buy
+1,837
New +$651K 0.72% 49

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dover Advisors's LLY Position: Q1 2026 in Review

Dover Advisors reduced its Eli Lilly (LLY) stake by 1.2% in Q1 2026, selling an estimated $20.3K and leaving 1,605 shares worth $1.48M. The position accounts for 0.61% of the portfolio, ranked #45.

Dover Advisors first reported a position in LLY in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.75M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Dover Advisors held 1,605 shares of Eli Lilly worth $1.48M as of Q1 2026.
  • Dover Advisors sold 20 Eli Lilly shares in Q1 2026, an estimated $20.3K.
  • Eli Lilly made up 0.61% of Dover Advisors's portfolio in Q1 2026, its #45 holding.
  • Dover Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 14 quarters since.
  • Dover Advisors's Eli Lilly position peaked at $1.75M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Dover Advisors's 13F filing for Q1 2026, filed 8 Apr 2026.